Keywords: xenical, meridia, drive, antiobesity, drugmarket, market, drugs

Xenical, Meridia drive US antiobesity drugmarket

Article | 15 November 1999

Print This

The US market for antiobesity drugs is expanding again, after theshrinkage caused by the withdrawal of Redux (dexfenfluramine) and Pondimin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in